(HealthDay News) — US Department of Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. has canceled nearly $500 million in grants and contracts meant to support mRNA vaccine development, ...

Event rates were lower during oseltamivir-treated influenza periods and posttreatment periods vs. untreated influenza ...

(HealthDay News) — A considerable proportion of adolescents and young adults eligible for glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are uninsured, and many young adults do not have a ...

Findings from key secondary endpoints showed 59.6% of patients taking orforglipron 36mg (highest dose) achieved a reduction in body weight of 10% or greater vs 8.6% of patients receiving placebo; ...

Class-wide label change for opioids; positive results for oral GLP-1; migraine prevention therapy approved for children; FDA removes restriction on Ixchiq for older adults; Modeyso approved for rare ...

In the most severe erosive esophagitis patients (LA grade C or D), tegoprazan 100mg was found to be statistically superior to lansoprazole for maintenance of healing at 24 weeks. Noninferiority vs ...

The randomized, double-blind, CONVOKE trial evaluated the safety and efficacy of CT-155, a PDT that provides interactive psychosocial intervention techniques via a smartphone app.

As part of a postmarketing requirement, Valneva will be initiating a study to assess the risk of severe chikungunya-like adverse reactions following administration of Ixchiq.

The Food and Drug Administration (FDA) has granted accelerated approval to Modeyso ™ (dordaviprone), a protease activator, for the treatment of adult and pediatric patients aged 1 year and older with ...

Cognitive functional therapy, with or without biofeedback, more effective than usual care for chronic disabling low back pain.

HealthDay News — Canagliflozin is associated with a clinically meaningful reduction in hemoglobin A1c (HbA1c) for children and adolescents with type 2 diabetes mellitus (T2DM), according to a study ...

Watchful waiting extended as initial management strategy for all patients with uncomplicated acute bacterial rhinosinusitis ...